PharmaBoardroom

Andy Suter – CEO, A. Vogel

A. Vogel CEO Dr Andy Suter outlines the Swiss herbal medicine market leader’s expansion in recent years, why it is prioritising R&D more than…

Swissmedic: Taking its Own Path

Regarded as one of the world’s leading regulatory bodies, Swissmedic stands alongside its equivalents in Europe, Japan, Canada, and Australia in…

Denmark Pharma Industry Snapshot 2021

Novo Nordisk, Lundbeck, and LEO Pharma are the major players in the Danish pharmaceutical industry, all with significant R&D and manufacturing…

Turkey Pharma Industry Data Snapshot 2021

According to a recent report by IEIS, Turkey’s Pharmaceutical Manufacturers Association, there are approximately 680 companies competing in the…

Tillotts CEO Talks SME M&A Principles

Thomas A. Tóth von Kiskér, longstanding CEO of Tillotts Pharma AG, a specialty pharma player focused on the digestive system, has overseen a number…

Georg Schroeckenfuchs of Novartis: ‘Shooting for the Moon’ in…

33-year pharma industry veteran Georg Schroeckenfuchs currently heads up the vast Middle East & Africa (MEA) region for Swiss behemoth Novartis,…

Switzerland’s Upcoming Cost Containment Packages: Industry…

While once considered the land of milk and honey within Europe in terms of market access and reimbursement for innovative pharmaceuticals, Switzerland…

Newly Independent CDMO Skyepharma Looks to Expansion

Fresh from a management buyout and the establishment of Skyepharma as an independent company, Managing Director David Lescuyer charts the fully…

Stefan Berg – General Manager, Pharmaplan AG Switzerland

Stefan Berg, general manager of Pharmaplan, one of the leading pharma engineering partners in Europe, outlines the key trends in this area, including…

René P Buholzer – CEO, Interpharma, Switzerland

Interpharma’s Dr René P. Buholzer highlights the key lessons that Switzerland’s innovative pharmaceutical industry has taken from the COVID-19…

APAC: Generic Penetration by Country

Generics penetration in the Asia-Pacific region by country for 2018. A full 90.3 percent of all medicines dispensed in India were generics compared to…

Biosimilars & Biologics: Mexico

Key facts about biosimilars and biologics in Mexico. Prepared in association with Olivares, a leading global law firm, this is an extract from The…

Tagged with Pharma